QurAlis to Present Data That Show its Splice-Switching ASOs Restore UNC13A Function in ALS and Frontotemporal Dementia
SV investment has resulted in the approval of 24 novel therapeutics
SV Health Investors bolsters senior biotech team - appoints Nikola Trbovic as Managing Partner and hires Jamil Beg as Partner
Hightop Health adds industry veteran to Board of Directors - Seasoned CEO and McLean Hospital Board Chair joins Hightop’s executive leadership
Merck to Acquire Caraway Therapeutics, Inc.
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
SV Health Investors partners with HIT Executives Dave Dyell and Marc Hirshfield to Lead Recapitalization of Innovative Consulting Group
- 10 August 2022Portfolio NewsArtios initiates Phase 2 study of Polθ Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BRCA Deficient Breast Cancer
- 10 August 2022SV NewsNumis adds International Biotech trust as ‘core buy’ on the back of rebound
- 9 August 2022Portfolio NewsNanopath Secures $10 Million in Series A Funding to Develop and Commercialize Point-of-Care Diagnostics for Women's Health
- 9 August 2022Portfolio NewsCerevance Establishes Strategic Research Collaboration with Merck for the Discovery of Novel Targets in Alzheimer’s Disease
- 9 August 2022Portfolio NewsOn heels of Parkinson’s readout, Cerevance enters Alzheimer’s discovery deal with Merck
- 17 July 2022SV NewsUK has missed chances to prepare for future pandemics, says [Kate Bingham] ex-vaccines tsar
- 13 July 2022Portfolio NewsFDA Grants Alpheus Medical Orphan Drug and Fast Track Designations for Novel Sonodynamic Therapy for Brain Cancer
- 6 July 2022Portfolio NewsNitrase Therapeutics Expands Leadership Team with Accomplished Drug Discovery and Development Executives
- 30 June 2022Portfolio NewsRia Health Secures $18 Million Series A to Scale Online Alcohol Use Disorder Treatment
- 21 June 2022Portfolio NewsQurAlis Announces the Appointment of Anne C. Whitaker as Chair of the Board
- 9 June 2022Portfolio NewsMemorial Hermann Health System Joins Existing Investors in Leiters, a 503B Outsourced Pharmaceutical Compounding Industry Leader
- 8 June 2022Portfolio NewsSV Health Investors announces acquisition of Nordic Consulting Partners by Accrete Health Partners, a strategic holding company of Bon Secours Mercy Health